Phase 3 COMP006 trial results demonstrate that COMP360, an investigational synthetic psilocybin formulation, provides a rapid and durable clinical benefit through 6 months in patients with chronic ...

Health experts criticize upcoming Pharmacy Compounding Advisory Committee participants for having financial interest in changing peptide policy.

California will replace "sell by" labels with labels using standardized language in an effort to reduce food waste.

Increased intake of sugar-sweetened beverages and fruit juice is associated with increase risk for hypertension.

Comorbid ASD in youth with ADHD is linked to greater healthcare utilization and distinct medication treatment patterns.

Assessing reduced stimulant use in clinical trials may reveal treatment benefits for cocaine and methamphetamine use disorders.

The Real Cost campaign successfully prevented youth from initiating e-cigarette use and reduced unauthorized sales.

Patients with dementia and agitation are more likely to transition to a more supportive living setting after psychiatric hospitalization.

A connectivity-based electric-field modeling approach identified potential transcranial magnetic stimulation targets for reducing PTSD symptoms.

Certain neurologic conditions, like epilepsy or stroke, appear to share a bidirectional association with traumatic brain injury.

Improved maternal cardiovascular health is associated with a reduced risk for developmental delay among children at age 4 years.

The FDA will allow several new nicotine pouch products to be marketed as a "lower-risk option" compared with cigarettes.